MetaCap

Grace Therapeutics Insider Trades

NASDAQ: GRCEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.08+0.04 (+1.96%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
12 · $473.70K
Sales
0 · $0
Shares bought / sold
225.35K / 0
Net activity
Net buying $473,699

Grace Therapeutics insider activity

Over the last 12 months, Grace Therapeutics insiders reported 12 transactions on SEC Form 4: 12 open-market purchases and 0 sales. Insiders bought $473,699 and sold $0 worth of stock, for net insider buying of $473,699. The most recent filing shows Opaleye Management Inc. (10% Owner) buying 1,694 shares at $2.06 on Oct 5, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GRCE's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

GRCE insider transactions

Grace Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Oct 5, 2026Opaleye Management Inc.10% OwnerBuy1,694$3.49KForm 4
Oct 2, 2026Opaleye Management Inc.10% OwnerBuy20,000$41.37KForm 4
Oct 1, 2026Opaleye Management Inc.10% OwnerBuy38,796$78.96KForm 4
Sep 29, 2026Opaleye Management Inc.10% OwnerBuy7,849$16.40KForm 4
Sep 23, 2026Opaleye Management Inc.10% OwnerBuy5,318$11.17KForm 4
Sep 23, 2026Opaleye Management Inc.10% OwnerBuy5,318$11.17KForm 4
Sep 21, 2026Opaleye Management Inc.10% OwnerBuy9,771$20.52KForm 4
Sep 21, 2026Opaleye Management Inc.10% OwnerBuy9,771$20.52KForm 4
Sep 9, 2026Kohli PrashantChief Executive OfficerBuy100,000$214.00KForm 4
Sep 9, 2026Opaleye Management Inc.10% OwnerBuy5,836$12.20KForm 4
Sep 8, 2026Opaleye Management Inc.10% OwnerBuy9,393$19.70KForm 4
Aug 14, 2026Opaleye Management Inc.10% OwnerBuy11,608$24.21KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related